MONTREAL, Nov. 3 /CNW Telbec/ - (TSX.V: BUG) - Biophage Pharma is very pleased to announce today that it is receiving substantial orders from Quebec and California clinics for MELISA(R) testing, a novel and advanced diagnostic tool for the detection of sensitization to more than 200 different allergenic substances.
